Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial
<h4>Background</h4> <p>Infections acquired in hospital are an important cause of morbidity and mortality in very preterm infants. Several small trials have suggested that supplementing the enteral diet of very preterm infants with lactoferrin, an antimicrobial protein processed fr...
Autors principals: | Griffiths, J, Jenkins, P, Vargova, M, Bowler, U, Juszczak, E, King, A, Linsell, L, Murray, D, Partlett, C, Patel, M, Berrington, J, Dorling, J, Embleton, N, Heath, P, Oddie, S, McGuire, W |
---|---|
Format: | Journal article |
Publicat: |
Elsevier
2019
|
Ítems similars
-
Enteral lactoferrin to prevent infection for very preterm infants: the ELFIN RCT
per: James Griffiths, et al.
Publicat: (2018-12-01) -
Enteral lactoferrin to prevent infection for very preterm infants: the ELFIN RCT
per: Griffiths, J, et al.
Publicat: (2018) -
Early enteral feeding strategies for very preterm infants: Current evidence from Cochrane reviews
per: Abbott, J, et al.
Publicat: (2013) -
Mechanisms affecting the gut of preterm infants in enteral feeding trials
per: Embleton, N, et al.
Publicat: (2017) -
Mechanisms Affecting the Gut of Preterm Infants in Enteral Feeding Trials
per: Nicholas D. Embleton, et al.
Publicat: (2017-05-01)